Head-to-head · Cost-Efficiency Index
GOAL.MD vs Queen RX
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
GOAL.MD
Shoppers comparing a named physician-led practice, who won't mistake the $149 ad price for the ongoing rate.
Visit GOAL.MDQueen RX
Cost-first shoppers who want a low one-time cost to try a GLP-1 without committing to a monthly subscription.
Visit Queen RXThe verdict
GOAL.MD and Queen RX tie on the Cost-Efficiency Index at 71/100, so neither wins outright on the numbers. For most shoppers we'd start with GOAL.MD (ranked #81, a hair above #82) — Shoppers comparing a named physician-led practice, who won't mistake the $149 ad price for the ongoing rate. But Queen RX is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs GOAL.MD.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | GOAL.MD | Queen RX |
|---|---|---|
| Cost-Efficiency Index | 71/100 | 71/100 |
| Semaglutide / mo | $199/mo (promotional rate, compounded) | $100/mo (starting dose, bundle, compounded) |
| Tirzepatide / mo | $299/mo (compounded) | $100/mo (bundle, compounded) |
| Semaglutide / yr (modeled) | $2,388 | $1,200 |
| Tirzepatide / yr (modeled) | $3,588 | $1,200 |
| Coverage | All 50 states | 45 states |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #81 | #82 |
GOAL.MD
71/100Where the value is
- Named Chief Physician (Dr. Michael Mimlitz, MD) rather than an anonymous provider network
- Multiple product tiers (standard, micro-dose, combination 'Synergy') for different budgets and needs
- 3-month bundle discount available on the combination product ($547/mo vs. $597/mo single-month)
The tradeoffs
- The widely advertised '$149' price is a first-month-only discount; the standing rate is $199/mo semaglutide and $299/mo tirzepatide — more than double the headline for tirzepatide
- No named compounding pharmacy — only generic '503A & 503B licensed U.S. pharmacies' language
Queen RX
71/100Where the value is
- Full refund if the physician determines you can't be prescribed anything
- No subscription or membership fee — a single $299 purchase covers a full 3-month course including supplies
- Works out to one of the lower per-month equivalents in this batch when averaged over the 3-month term
The tradeoffs
- Not actually a monthly price — it's a one-time $299 purchase per 3-month term; there is no month-to-month billing option at all
- No price differentiation between semaglutide, tirzepatide, and liraglutide — all fall under the same $299 bundle regardless of which drug is prescribed or its dose
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.